AASDH | Aminoadipate-semialdehyde dehydrogenase | Predicted membrane proteins
| | | | | Expressed in all |
ABCA1 | ATP-binding cassette, sub-family A (ABC1), member 1 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCA5 | ATP-binding cassette, sub-family A (ABC1), member 5 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCA9 | ATP-binding cassette, sub-family A (ABC1), member 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB5 | ATP-binding cassette, sub-family B (MDR/TAP), member 5 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB6 | ATP-binding cassette, sub-family B (MDR/TAP), member 6 | Disease related genes Mitochondrial proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCB7 | ATP-binding cassette, sub-family B (MDR/TAP), member 7 | Disease related genes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCB9 | ATP-binding cassette, sub-family B (MDR/TAP), member 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCC10 | ATP-binding cassette, sub-family C (CFTR/MRP), member 10 | Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCC3 | ATP-binding cassette, sub-family C (CFTR/MRP), member 3 | Cancer-related genes Predicted membrane proteins Transporters
| | | | | Mixed |
ABCC8 | ATP-binding cassette, sub-family C (CFTR/MRP), member 8 | Disease related genes FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCD1 | ATP-binding cassette, sub-family D (ALD), member 1 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABCD4 | ATP-binding cassette, sub-family D (ALD), member 4 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Expressed in all |
ABHD1 | Abhydrolase domain containing 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enriched |
ABHD16A | Abhydrolase domain containing 16A | Predicted membrane proteins
| | | | | Expressed in all |
ABHD3 | Abhydrolase domain containing 3 | Predicted membrane proteins
| | | | | Expressed in all |
ACKR2 | Atypical chemokine receptor 2 | G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enriched |
ACSF2 | Acyl-CoA synthetase family member 2 | Mitochondrial proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ACSL1 | Acyl-CoA synthetase long-chain family member 1 | Enzymes Mitochondrial proteins Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ACSL6 | Acyl-CoA synthetase long-chain family member 6 | Cancer-related genes Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ACSM1 | Acyl-CoA synthetase medium-chain family member 1 | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ACSM2A | Acyl-CoA synthetase medium-chain family member 2A | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Group enriched |
ACSM2B | Acyl-CoA synthetase medium-chain family member 2B | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Group enriched |
ACSM4 | Acyl-CoA synthetase medium-chain family member 4 | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Not detected |
ACSS1 | Acyl-CoA synthetase short-chain family member 1 | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
ADAM20 | ADAM metallopeptidase domain 20 | Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
ADCY4 | Adenylate cyclase 4 | Enzymes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
ADIPOR1 | Adiponectin receptor 1 | Predicted membrane proteins
| | | | | Expressed in all |
ADORA3 | Adenosine A3 receptor | FDA approved drug targets G-protein coupled receptors Predicted membrane proteins
| | | | | Tissue enhanced |
ADTRP | Androgen-dependent TFPI-regulating protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AFG3L2 | AFG3-like AAA ATPase 2 | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGMO | Alkylglycerol monooxygenase | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
AGPAT2 | 1-acylglycerol-3-phosphate O-acyltransferase 2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
AGPAT4 | 1-acylglycerol-3-phosphate O-acyltransferase 4 | Enzymes Predicted membrane proteins
| | | | | Mixed |
AGPAT5 | 1-acylglycerol-3-phosphate O-acyltransferase 5 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
AGPAT6 | 1-acylglycerol-3-phosphate O-acyltransferase 6 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
AGPAT9 | 1-acylglycerol-3-phosphate O-acyltransferase 9 | Enzymes Predicted membrane proteins
| | | | | Expressed in all |
AIG1 | Androgen-induced 1 | Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ALDH16A1 | Aldehyde dehydrogenase 16 family, member A1 | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
ALDH3A2 | Aldehyde dehydrogenase 3 family, member A2 | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ALDH3B2 | Aldehyde dehydrogenase 3 family, member B2 | Enzymes Predicted membrane proteins
| | | | | Tissue enhanced |
ALG10 | ALG10, alpha-1,2-glucosyltransferase | Enzymes Predicted membrane proteins
| | | | | Mixed |
ALG10B | ALG10B, alpha-1,2-glucosyltransferase | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Mixed |
ALG11 | ALG11, alpha-1,2-mannosyltransferase | Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Expressed in all |
ANO1 | Anoctamin 1, calcium activated chloride channel | FDA approved drug targets Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANO10 | Anoctamin 10 | Disease related genes Predicted membrane proteins
| | | | | Expressed in all |
APOL1 | Apolipoprotein L, 1 | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Expressed in all |
APOL2 | Apolipoprotein L, 2 | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
APOO | Apolipoprotein O | Mitochondrial proteins Predicted membrane proteins
| | | | | Expressed in all |
AQP7 | Aquaporin 7 | Predicted membrane proteins
| | | | | Tissue enhanced |